Using bc-GenExMiner 4.5, IDO2 expression was assessed in the PAM50 molecular subtypes of breast cancer, in a combined dataset of 4387 samples (TCGA, SCAN-B/GSE96058, and SCAN-B/GSE81538). Here, IDO2 is linked to breast cancer.